Investigator meeting · Dr. Andrea Weber

14 May 2026 · In person · Dr. Andrea Weber, McGill University Health Centre · MSL James Whitfield · Lumeva

ReviewedVeeva CRMENG-0215MI request

Capture insight from this engagement

Location: McGill University Health Centre
Therapeutic area: Neurology
Country: Canada
Stakeholder tier: Tier 1
Strategic objective: Not linked
Initiative: Not linked
MSL: JWJames WhitfieldSenior MSL, Oncology (US East)
Product: Lumeva (lumevarin)

Topics discussed

Real-world persistence
Medication-overuse headache
Switching between CGRP agents

Scientific content used

LMV persistence data summary
Chronic migraine scientific platform

Questions raised

Any data in patients with medication-overuse headache?
Is there guidance on switching from a monoclonal antibody?

Notes

Investigator meeting with general neurologist at McGill University Health Centre. Discussed real-world persistence, medication-overuse headache, switching between cgrp agents.

Insights captured (0)

Capture insight

No insights captured from this engagement.

Review workflow

Draft
Submitted
3Reviewed

Review complete. Quality ratings and insights can now be used in aggregates.

Follow-ups

Share MI standard response

0 of 1 complete

Quality ratings

1–5, rated at review

Scientific relevance: 5
Strategic relevance: 3
Depth of exchange: 4
Actionability: 2

Data lineage

Source system: Veeva CRM
Sync: Veeva CRM · synced 2026-09-15 08:00 UTC
System of record: Veeva CRM
Record id: ENG-0215

Audit history (0)

All create, update and approval events for this record

No audit events in sample data